OACC Oaktree Acquisition Corp. III Life Sciences: institutional ownership and insider trading
54 funds reported holding $191M of Oaktree Acquisition Corp. III Life Sciences in their latest 13F filings; in Q2 2026 funds net bought $674K, with 2 new positions and 2 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Famous investors holding OACC
- D. E. Shaw (D. E. Shaw & Co.): $9.23M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $4.68M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $1.87M, 0.0% of the portfolio
Largest institutional holders of OACC
- AQR Arbitrage LLC — $14.2M
- Fort Baker Capital Management LP — $11.8M
- Decagon Asset Management LLP — $11.7M
- Empyrean Capital Partners, LP — $9.63M
- D. E. Shaw & Co., Inc. — $9.23M
- BOUSSARD & GAVAUDAN GESTION SAS — $7.70M
- Boussard & Gavaudan Investment Management LLP — $7.62M
- LINDEN ADVISORS LP — $6.43M
- TORONTO DOMINION BANK (TD, TDBCP) — $5.93M
- Sculptor Capital LP — $5.68M
5%+ owners
- Barclays PLC: 7.0% (Schedule 13G, filed Aug 13, 2026)
- THE GOLDMAN SACHS GROUP, INC.: 6.2% (Schedule 13G, filed May 11, 2026)
- Decagon Asset Management LLP: 5.5% (Schedule 13G, filed Aug 14, 2026)
- Fort Baker Capital Management LP: 5.1% (Schedule 13G, filed May 15, 2026)